115 related articles for article (PubMed ID: 3829597)
1. Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome.
Di Virgilio F; Calò L; Cantaro S; Favaro S; Piccoli A; Borsatti A
Clin Sci (Lond); 1987 Apr; 72(4):483-8. PubMed ID: 3829597
[TBL] [Abstract][Full Text] [Related]
2. Intracellular calcium signalling and vascular reactivity in Bartter's syndrome.
Calò L; D'Angelo A; Cantaro S; Rizzolo M; Favaro S; Antonello A; Borsatti A
Nephron; 1996; 72(4):570-3. PubMed ID: 8730423
[TBL] [Abstract][Full Text] [Related]
3. Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils.
Andersson T; Dahlgren C; Pozzan T; Stendahl O; Lew PD
Mol Pharmacol; 1986 Nov; 30(5):437-43. PubMed ID: 2430168
[TBL] [Abstract][Full Text] [Related]
4. Plasma membrane potential modulates chemotactic peptide-stimulated cytosolic free Ca2+ changes in human neutrophils.
Di Virgilio F; Lew PD; Andersson T; Pozzan T
J Biol Chem; 1987 Apr; 262(10):4574-9. PubMed ID: 2435712
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil function in Bartter's syndrome.
Lapointe N; Samson J; O'Regan S
Prostaglandins Med; 1981 Jun; 6(6):647-55. PubMed ID: 6267641
[TBL] [Abstract][Full Text] [Related]
6. Role of cytosolic free calcium and phospholipase C in leukotriene-B4-stimulated secretion in human neutrophils. Comparison with the chemotactic peptide formyl-methionyl-leucyl-phenylalanine.
Lew PD; Monod A; Waldvogel FA; Pozzan T
Eur J Biochem; 1987 Jan; 162(1):161-8. PubMed ID: 3028787
[TBL] [Abstract][Full Text] [Related]
7. Origin of intracellular calcium and quantitation of mobilizable calcium in neutrophils stimulated with chemotactic peptide.
Hamachi T; Hirata M; Koga T
Biochim Biophys Acta; 1986 Nov; 889(2):136-48. PubMed ID: 2430624
[TBL] [Abstract][Full Text] [Related]
8. Chemotactic factor receptor activation transiently impairs the Ca2+ signaling capacity of beta 2 integrins on human neutrophils.
Eierman D; Hellberg C; Sjölander A; Andersson T
Exp Cell Res; 1994 Nov; 215(1):90-6. PubMed ID: 7525325
[TBL] [Abstract][Full Text] [Related]
9. Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogue.
Seifert R; Höer A; Offermanns S; Buschauer A; Schunack W
Mol Pharmacol; 1992 Aug; 42(2):227-34. PubMed ID: 1381043
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP inhibition of fMet-Leu-Phe-dependent metabolic responses in human neutrophils is not due to its effects on cytosolic Ca2+.
De Togni P; Cabrini G; Di Virgilio F
Biochem J; 1984 Dec; 224(2):629-35. PubMed ID: 6097226
[TBL] [Abstract][Full Text] [Related]
11. Correction of hypokalemia corrects the abnormalities in erythrocyte sodium transport in Bartter's syndrome.
Korff JM; Siebens AW; Gill JR
J Clin Invest; 1984 Nov; 74(5):1724-9. PubMed ID: 6501567
[TBL] [Abstract][Full Text] [Related]
12. Verapamil impairs human neutrophil chemotaxis by a non-calcium-mediated mechanism.
Pennington JE; Kemmerich B; Kazanjian PH; Marsh JD; Boerth LW
J Lab Clin Med; 1986 Jul; 108(1):44-52. PubMed ID: 3711725
[TBL] [Abstract][Full Text] [Related]
13. Inositol phosphate formation in fMet-Leu-Phe-stimulated human neutrophils does not require an increase in the cytosolic free Ca2+ concentration.
Di Virgilio F; Vicentini LM; Treves S; Riz G; Pozzan T
Biochem J; 1985 Jul; 229(2):361-7. PubMed ID: 4038273
[TBL] [Abstract][Full Text] [Related]
14. Cytosolic free calcium changes induced by chemotactic peptide in neutrophils from patients with chronic granulomatous disease.
Lew PD; Wollheim C; Seger RA; Pozzan T
Blood; 1984 Jan; 63(1):231-3. PubMed ID: 6689950
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of plasma atrial natriuretic peptide in Bartter's syndrome fall to normal with indomethacin: implications for atrial natriuretic peptide regulation in man.
Gordon RD; Tunny TJ; Klemm SA; Hamlet SM
J Hypertens Suppl; 1986 Dec; 4(6):S555-8. PubMed ID: 2956391
[TBL] [Abstract][Full Text] [Related]
16. [Blood glucose regulation in Bartter's syndrome. Observations in 2 cases].
Uccella R; Agosti C; Morenghi R; Morgutti M
Minerva Med; 1983 Mar; 74(9-10):453-63. PubMed ID: 6340001
[TBL] [Abstract][Full Text] [Related]
17. The dependence on Ca2+ of phosphatidylinositol breakdown and enzyme secretion in rabbit neutrophils stimulated by formylmethionyl-leucylphenylalanine or ionomycin.
Cockcroft S; Bennett JP; Gomperts BD
Biochem J; 1981 Dec; 200(3):501-8. PubMed ID: 7342966
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte sodium transport in Bartter's syndrome.
Uchiyama M; Shah V; Daman Willems C; Dillon MJ
Acta Paediatr Scand; 1988 Nov; 77(6):873-8. PubMed ID: 2849851
[TBL] [Abstract][Full Text] [Related]
19. Characterization of formylmethionyl-leucyl-phenylalanine stimulation of inositol trisphosphate accumulation in rabbit neutrophils.
Bradford PG; Rubin RP
Mol Pharmacol; 1985 Jan; 27(1):74-8. PubMed ID: 2981403
[TBL] [Abstract][Full Text] [Related]
20. The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome.
Horký K; Schreiber V; Dvoráková J
Exp Clin Endocrinol; 1984 Jul; 84(1):105-11. PubMed ID: 6090182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
